Michigan Sets a Standard in Radiation Emergency Preparedness
Michigan's efforts in radiation emergency preparedness showcase a proactive approach that could serve as a model for health officials nationwide.
Concerns Rise Over Hantavirus Outbreak on Dutch Cruise Ship
A suspected hantavirus outbreak on a Dutch cruise ship has led to the deaths of three passengers, raising alarms about health safety on cruises.
Health Update on Two Britons Evacuated from Hantavirus-Affected Ship
Two Britons evacuated from a cruise ship affected by hantavirus are reportedly improving in their respective hospitals, one in Johannesburg and the other in the Netherlands.
Real Madrid Players in Crisis Meeting Following Training Ground Altercation
Real Madrid's training ground has become the site of a crisis meeting after a series of altercations involving midfielders Federico Valverde and Aurelien Tchouameni, leading to Valverde's hospitalization.
Health Officials Monitor Departures from Hantavirus-Affected Ship Following Fatality
In the wake of the first reported death linked to a hantavirus outbreak on a ship, health officials are actively tracking individuals who left the vessel.
Concerns Rise Over Political Interference in FDA Drug Approvals
Recent developments suggest that a political appointee may be obstructing the approval process for a Sanofi drug, raising alarms about potential political interference at the FDA.
Efforts Underway to Locate Passengers from Hantavirus-Linked Cruise Ship
Authorities are working to trace passengers who disembarked from the MV Hondius at St Helena, following the death of a 69-year-old woman in South Africa.
Sanofi Withdraws Teplizumab from FDA Fast-Track Review Amid Internal Disagreements
Sanofi has requested the FDA to withdraw teplizumab from its fast-track review program following internal disagreements regarding the drug's approval.
FDA to Reassess Ebvallo After Unexpected Rejection
Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.
Rising Trend of Hospital Shootings Since 2000 Raises Concerns
A recent report indicates a steady increase in hospital shootings since 2000, highlighting a troubling trend in healthcare safety and security.
Argentina Investigates Potential Hantavirus Outbreak from Cruise Ship
Health officials in Argentina are urgently working to identify the origins of a hantavirus outbreak linked to the MV Hondius cruise ship, as some passengers have returned to the US.
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
In a significant move within the pharmaceutical industry, Angelini Pharma has announced its acquisition of Catalyst Pharmaceuticals, a company specializing in treatments for rare diseases, for $4.1 billion.
Understanding Variability in Parkinson's Treatment Response
A recent study utilizing machine learning has revealed previously unrecognized forms of Parkinson's disease, potentially shedding light on the varying effectiveness of treatments among patients.
Concerns Rise Over Hantavirus Outbreak Linked to Cruise Ship
Health officials express alarm over a hantavirus outbreak involving the Andes strain, as the WHO works to alleviate public anxiety about potential pandemic risks.
Fort Drum Commander Seeks State Support for Nuclear Energy and Healthcare Initiatives
The commander of Fort Drum has called on state officials to back initiatives in nuclear energy and healthcare, highlighting the importance of these sectors.
Contradictions in Trump Administration's Drug Policy Raise Concerns
The Trump administration's recent actions regarding drug policy appear inconsistent, as the White House endorses treatment methods while imposing new restrictions.
Bacterial protein map could open new path against drug-resistant infections
La Trobe scientists have made a pivotal discovery in the fight against dangerous drug-resistant bacteria.
The Case for 'Most Favored Nation' Drug Pricing: A Timely Discussion
As discussions around pharmaceutical pricing evolve, the 'Most Favored Nation' model emerges as a potential solution worth considering for its implications and benefits.
Sanofi Seeks FDA Withdrawal of Diabetes Drug from Fast-Track Review Amid Political Concerns
In a notable move, Sanofi has requested the FDA to withdraw its type 1 diabetes drug from the expedited review process, citing political interference as a key factor.
Color Health Ventures into Cancer Care with New Virtual Tumor Boards
Color Health is broadening its services to include cancer care coordination, aiming to fill a significant void in the healthcare landscape.